InvestorsHub Logo
Followers 120
Posts 11038
Boards Moderated 0
Alias Born 01/20/2009

Re: None

Tuesday, 12/19/2017 10:29:18 AM

Tuesday, December 19, 2017 10:29:18 AM

Post# of 3582
CEO Barbier commented that they are in advanced negotiations with "more than one party." These discussions range from "potential M&A to a licensing deal." He commented that these interested parties value the drug, and the company, in ways that are "vastly different than the way investors value a company." This comment suggests to me that he believes that the company is deeply undervalued, and that we will get a significant premium for shareholders when a deal is executed.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SAVA News